Otsuka Holdings Co., Ltd. (TYO:4578)

Market Cap	5.95T +57.9%
Revenue (ttm)	2.52T +5.1%
Net Income	376.50B +7.3%
EPS	712.99 +9.7%
Shares Out	526.52M
PE Ratio	15.85
Forward PE	18.46
Dividend	140.00 (1.24%)
Ex-Dividend Date	Jun 29, 2026

Volume	553,600
Open	11,350
Previous Close	11,300
Day's Range	11,300 - 11,625
52-Week Range	6,511 - 11,910
Beta	-0.05
Analysts	Buy
Price Target	12,900.00 (+11.21%)
Earnings Date	Jul 31, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 37,758
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4578

Financial Performance

In 2025, Otsuka Holdings's revenue was 2.47 trillion, an increase of 5.97% compared to the previous year's 2.33 trillion. Earnings were 363.15 billion, an increase of 5.84%.

Analyst Summary

According to 12 analysts, the average rating for 4578 stock is "Buy." The 12-month stock price target is ¥12,900, which is an increase of 11.21% from the latest price.

Price Target

¥12,900

(11.21% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 6, 2026

Data Sources Report a data error